Skip to main content
. 2013 Aug 20;27(12):1081–1092. doi: 10.1007/s40263-013-0104-8

Fig. 1.

Fig. 1

Study design. Visit window ±2 days throughout the evaluation period. Visit window +2 days for safety follow-up visit. ATX atomoxetine, ET early termination, LDX lisdexamfetamine dimesylate, V visit